AMAG Pharma (AMAG) Shares Rally Sharply Following Ladenburg Upgrade

Shares of AMAG Pharmaceuticals (NASDAQ: AMAG) just jumped very sharply in mid-day trade Thursday morning following an intraday upgrade from Ladenburg Thalmann's Juan Sanchez. The analyst now rates the stock a Buy, up from Neutral previously. Sanchez set a new $15 price target.

AMAG shares are now up 4 percent to $13. Sanchez's new price target represents potential upside of about 15 percent.

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Johnson Rice Upgrades Big Sky Industrials (BSIN) to Buy
• Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy